-
Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General Population
van Son, K. C., de Jong, J. C. B. C., Özsezen, S., Caspers, M. P. M., Augustijn, Q. J. J., Snabel, J., Galenkamp, H., Hamer, H. M., van Dijk, A.-M., van Koppen, A., Mak, A. L., van den Born, B.-J., Nieuwdorp, M., Drenth, J. P. H., Gluud, L. L., Tushuizen, M. E., Hanemaaijer, R., Verschuren, L. & Holleboom, A. G., 1 Jul 2025, In: Liver International. 45, 7, e70169.Research output: Contribution to journal › Article › Academic › peer-review
-
Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis
Augustijn, Q. J. J., Grefhorst, A., de Groen, P., Wortelboer, K., Seegers, J. F. M. L., Gül, I. S., Suenaert, P., Verheij, J., de Vos, W. M., Herrema, H., Nieuwdorp, M. & Holleboom, A. G., 9 Jan 2025, In: BMJ open. 15, 1, e088290.Research output: Contribution to journal › Article › Academic › peer-review
-
Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice
Mak, A. L., Augustijn, Q. J. J., Heymann, C. J. F., Havik, S., Verdoes, X., Rios-Morales, M., Bosmans, L. A., Verheij, J., Meijnikman, A. S., de Jonge, P. A., Herrema, H., de Vos, W. M., Nieuwdorp, M., Grefhorst, A. & Holleboom, A. G., 1 Mar 2024, In: International journal of molecular sciences. 25, 6, 3481.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
